Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 56
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| capsule | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| intra-cellular therapies, inc | 3 |
Exclusivity
Patents and exclusivities
56| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10464938 | CAPLYTAlumateperone tosylate | product | Mar 2028 |
| 9199995 | CAPLYTAlumateperone tosylate | use | Mar 2029 |
| 9586960 | CAPLYTAlumateperone tosylate | substance, product | Mar 2029 |
| RE48825 | CAPLYTAlumateperone tosylate | substance, product | Mar 2029 |
| 10117867 | CAPLYTAlumateperone tosylate | use | May 2029 |
| 9168258 | CAPLYTAlumateperone tosylate | product | May 2029 |
| 9616061 | CAPLYTAlumateperone tosylate | product | May 2029 |
| 8648077 | CAPLYTAlumateperone tosylate | substance, product | Dec 2029 |
| RE48839 | CAPLYTAlumateperone tosylate | use | Aug 2033 |
| 10960009 | CAPLYTAlumateperone tosylate | use | Dec 2034 |
| 11026951 | CAPLYTAlumateperone tosylate | use | Dec 2034 |
| 9956227 | CAPLYTAlumateperone tosylate | use | Dec 2034 |
| 12409176 | CAPLYTAlumateperone tosylate | use | Mar 2039 |
| 10695345 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 11052084 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 11690842 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 11806348 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 12070459 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 12128043 | CAPLYTAlumateperone tosylate | product | Aug 2039 |
| 11980617 | CAPLYTAlumateperone tosylate | use | Oct 2039 |
| 12090155 | CAPLYTAlumateperone tosylate | product | Jul 2040 |
| 12122792 | CAPLYTAlumateperone tosylate | product | Dec 2040 |
| 12410195 | CAPLYTAlumateperone tosylate | product | Dec 2040 |
| Product | Exclusivity | Until |
|---|---|---|
| CAPLYTALUMATEPERONE TOSYLATE | M-319 Miscellaneous | Apr 2029 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CAPLYTA | lumateperone | capsule, oral | 72060-110NDA |
| CAPLYTA | lumateperone | capsule, oral | 72060-121NDA |
| CAPLYTA | lumateperone | capsule, oral | 72060-142NDA |
Compare
Other companies listing lumateperone
- Patheon Manufacturing Services LLC19 sites · 319 NDC
Enquiry
Common questions
- Is Intra-Cellular Therapies, Inc FDA approved?
- Intra-Cellular Therapies, Inc holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Intra-Cellular Therapies, Inc make?
- 3 products are listed under Intra-Cellular Therapies, Inc in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.